Items Tagged ‘Recurrent Breast Cancer’

June 28, 2013

Afinitor Provides Benefit in Advanced, HER2-Positive Breast Cancer

By

Among women with advanced HER2-positive breast cancer and resistance to Herceptin® (trastuzumab), a treatment regimen that included Afinitor® (everolimus) delayed cancer progression. The results of this Phase III clinical trial were presented at the 2013 Annual Meeting of the American Society of Clinical Oncology (ASCO). Afinitor is an oral medication that works by inhibiting a […]

View full entry

Tags: Breast Cancer, Metastatic Breast Cancer, Recurrent Breast Cancer


December 2, 2010

Effexor Preferred over Neurontin for Hot Flashes Among Breast Cancer Survivors

By

Women with a history of breast cancer appear to prefer the antidepressant Effexor® (venlafaxine) over the antiseizure drug Neurontin® (gabapentin) for treatment of hot flashes. These findings were recently released in the Journal of Clinical Oncology. Hot flashes can be a significant problem in women with a history of breast cancer. Given concerns regarding the […]

View full entry

Tags: Breast Cancer, Recurrent Breast Cancer, Stage I Node Negative Breast Cancer, Stages II-III Breast Cancer


October 30, 2008

Number of Circulating Cancer Cells Associated with Survival in Advanced Breast Cancer

By

Number of Circulating Cancer Cells Associated with Survival in Advanced Breast Cancer Cancer cells found circulating in the blood are a strong predictor of mortality among patients with metastatic breast cancer. Patients with large numbers of cancer cells found circulating in the blood may benefit from more aggressive or novel therapeutic approaches. These results were […]

View full entry

Tags: Breast Cancer, Metastatic Breast Cancer, Recurrent Breast Cancer


October 8, 2008

Nexavar® May Overcome Resistance to Arimidex® in Breast Cancer

By

Nexavar® May Overcome Resistance to Arimidex® in Breast Cancer The addition of Nexavar® (sorafenib) to Arimidex® (anastrozole) helps restore sensitivity to Arimidex among women with breast cancer. These results were recently presented at the 2008 annual American Society of Clinical Oncology (ASCO) breast cancer symposium. The majority of breast cancers are hormone positive, meaning that […]

View full entry

Tags: Breast Cancer, Recurrent Breast Cancer


September 26, 2008

Continuous Low-dose Chemotherapy Effective Against Anthracycline-resistant Breast Cancer

By

Continuous Low-dose Chemotherapy Effective Against Anthracycline-resistant Breast Cancer The use of low-dose Taxotere? (docetaxel) on a weekly basis plus Xeloda? (capecitabine) on a daily basis provided benefit for a significant portion of patients with breast cancer that has stopped responding to anthracyclines. The addition of Celebrex? (celecoxib), however, did not provide any additional benefit. These […]

View full entry

Tags: Breast Cancer, Recurrent Breast Cancer